Lantheus Holdings, Inc. (LNTH) Stock Forecast
Data as of May 3, 2026Healthcare · Current price $85.69 (+1.32%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Apr 15, 2026 | Richard Newitter | Truist Financial | $98.00 | +14.4% |
| Apr 13, 2026 | Anthony Petrone | Mizuho Securities | $95.00 | +10.9% |
| Mar 17, 2026 | Matthew Taylor | Jefferies | $110.00 | +28.4% |
| Feb 27, 2026 | Richard Newitter | Truist Financial | $89.00 | +3.9% |
| Dec 11, 2025 | Richard Newitter | Truist Financial | $80.00 | -6.6% |
| Aug 11, 2025 | Richard Newitter | Truist Financial | $63.00 | -26.5% |
| Dec 18, 2024 | Paul Choi | Goldman Sachs | $143.00 | +66.9% |
| Sep 3, 2024 | Ed Ridley-Day | Redburn Partners | $175.00 | +104.2% |
| Aug 1, 2024 | David Turkaly | JMP Securities | $125.00 | +45.9% |
| Jul 12, 2024 | Anthony Petrone | Mizuho Securities | $165.00 | +92.5% |
Top Analysts Covering LNTH
LNTH vs Sector & Market
| Metric | LNTH | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.18 | 2.24 | 2.41 |
| Analyst Count | 11 | 8 | 18 |
| Target Upside | +17.9% | +1150.3% | +14.9% |
| P/E Ratio | 25.43 | 6.84 | 31.19 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $1.41B | $1.45B | $1.57B | 11 |
| 2027-03-31 | $376M | $385M | $399M | 4 |
| 2027-06-30 | $393M | $402M | $417M | 3 |
| 2027-09-30 | $406M | $415M | $431M | 3 |
| 2027-12-31 | $426M | $435M | $451M | 3 |
| 2028-03-31 | $482M | $493M | $511M | 2 |
| 2028-06-30 | $513M | $525M | $544M | 5 |
| 2028-09-30 | $543M | $556M | $576M | 4 |
| 2028-12-31 | $571M | $584M | $606M | 4 |
| 2029-12-31 | $1.91B | $1.99B | $2.20B | 4 |
| 2030-12-31 | $2.10B | $2.19B | $2.42B | 4 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $5.01 | $5.19 | $5.63 | 8 |
| 2027-03-31 | $1.32 | $1.36 | $1.42 | 3 |
| 2027-06-30 | $1.39 | $1.43 | $1.49 | 5 |
| 2027-09-30 | $1.43 | $1.47 | $1.54 | 3 |
| 2027-12-31 | $1.93 | $1.98 | $2.08 | 6 |
| 2028-03-31 | $1.49 | $1.53 | $1.60 | 4 |
| 2028-06-30 | $1.60 | $1.65 | $1.73 | 6 |
| 2028-09-30 | $1.71 | $1.76 | $1.85 | 4 |
| 2028-12-31 | $2.62 | $2.70 | $2.83 | 7 |
| 2029-12-31 | $7.20 | $7.62 | $8.67 | 1 |
| 2030-12-31 | $7.97 | $8.44 | $9.60 | 1 |
Frequently Asked Questions
What is the analyst consensus for LNTH?
The consensus among 11 analysts covering Lantheus Holdings, Inc. (LNTH) is Buy with an average price target of $101.00.
What is the highest price target for LNTH?
The highest price target for LNTH is $175.00, set by Ed Ridley-Day at Redburn Partners on 2024-09-03.
What is the lowest price target for LNTH?
The lowest price target for LNTH is $63.00, set by Richard Newitter at Truist Financial on 2025-08-11.
How many analysts cover LNTH?
11 analysts have issued ratings for Lantheus Holdings, Inc. in the past 12 months.
Is LNTH a buy or sell right now?
Based on 11 analyst ratings, LNTH has a consensus rating of Buy (2.18/5) with a +17.9% upside to the consensus target of $101.00.
What are the earnings estimates for LNTH?
Analysts estimate LNTH will report EPS of $5.19 for the period ending 2026-12-31, with revenue estimated at $1.45B.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.